Hilliard Lyons Starts Meridian Biosciences (VIVO) at Long-Term Buy
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $33.97 --0%
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Hilliard Lyons initiated coverage on Meridian Biosciences (NASDAQ: VIVO) with a Long-Term Buy rating and a price target of $23.50.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $18.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Starts Bitfarms Ltd. (BITF) at Outperform
- H.C. Wainwright Starts Processa Pharmaceuticals (PCSA) at Buy
- Craig-Hallum Assumes DiaMedica Therapeutics Inc. (DMAC) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Hilliard LyonsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
